Arvie Camille V de Guzman

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Human Serum Albumin

Ejection Fraction

Top Venues

Clinical and translational medicine

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Doyeon Kim, Tin Tin Manh Nguyen, Yechan Moon, Jin-Mo Kim, Hoonsik Nam, Dong Seok Cha, Yong Jin An, Arvie Camille V de Guzman, Sunghyouk Park
Time-Resolved Evaluation of L-Dopa Metabolism in Bacteria-Host Symbiotic System and the Effect on Parkinson's Molecular Pathology. Small methods (2024)
Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)
Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)
Han Sun Kim, Doyeon Kim, Jiwoo Kim, Sunghyouk Park, Arvie Camille V de Guzman
SCD and MTHFD2 inhibitors for high-risk acute myeloid leukaemia patients, as suggested by ELN2017-pathway association. Clinical and translational medicine 13 (7) (2023)
Arvie Camille V de Guzman, Md Abdur Razzak, Joong Hee Cho, Ji Yi Kim, Shin Sik Choi
Curcumin-Loaded Human Serum Albumin Nanoparticles Prevent Parkinson's Disease-like Symptoms in C. elegans . Nanomaterials (Basel, Switzerland) 12 (5) (2022)